Dr. Brooke N. McQueen, MD

Dr. McQueen practices at Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System.

Dr. McQueen's NPI, 1932429354, was assigned on June 8, 2010. Dr. McQueen holds Oklahoma license 33618.

Dr. McQueen's primary practice is Saint Francis Hospital, at 6161 South Yale, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 494-8467.

Dr. McQueen's primary practice is Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System. Dr. McQueen is also affiliated with Saint Francis Hospital South. The medical group on file is Warren Clinic. Dmand AI also links Dr. McQueen to 4 more hospitals, 5 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McQueen practices, 8 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. McQueen's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. McQueen is licensed in Oklahoma.

CMS data shows 1,322 Medicare services from Dr. McQueen across 10 procedure codes in 2024, for 754 Medicare patients. Medicare paid $102,439 for them.

CMS counts 754 Medicare patients who saw Dr. McQueen in 2024. The largest group is 65 to 74, with 272 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McQueen's median patient age at 62, with 59% women.

In 2024, Dr. McQueen wrote 2,615 Medicare Part D claims for 268 patients. 78% of them were for generic drugs. CMS names the drug for 2,388 of them, across 47 drugs with 11 or more claims each, at $823,628 in total drug cost. In 2023, CMS named 2,693 claims across 52 drugs.

Dr. McQueen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 611 general payments to Dr. McQueen from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Supernus Pharmaceuticals, Inc. paid the most, $1,020.